With the changes in disease spectrum and the popularization of screening of low-dose spiral CT (CT) in the chest, more and more pulmonary nodules have been detected, most of which are bipulmonary multiple nodules. The existence of multiple pulmonary nodules means that it may be a pathological state of benign and malignant co-existence. The origin and evolution of pulmonary nodules in different histopathological states have a great impact on the choice of treatment methods. In recent years, the rise of immunotherapy has brought a breakthrough in the treatment of refractory lung cancer. However, some patients are still ineffective in immunotherapy, which may be related to the immune microenvironment where nodules are proportioned in different components in different pathological states. This review article mainly predicts the development process of nodules by analyzing the origin of multiple pulmonary nodules and the immune microenvironment of nodules in different pathological conditions, so as to provide guidance for clinical treatment.
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. https://doi.org/10.3322/caac.21590
Fang, B. (2016) RAS Signaling and Anti-RAS Therapy: Lessons Learned from Genetically Engineered Mouse Models, Human Cancer Cells, and Patient-Related Studies. Acta Biochimica et Biophysica Sinica (Shanghai), 48, 27-38. https://doi.org/10.1093/abbs/gmv090
Annemie, S., Amélie, D., Laurens, C., et al. (2017) Wolf in Sheep’s Clothing: Primary Lung Cancer Mimicking Benign Entities. Lung Cancer, 112, 109-117. https://doi.org/10.1016/j.lungcan.2017.07.037
Brendon, S. (2016) Re: Discrepancy of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma Presenting as Multiple Ground-Glass Opacities. European Journal of Cardio-Thoracic Surgery, 50, 913. https://doi.org/10.1093/ejcts/ezw148
Kobayashi, Y., Mitsudomi, T., Sakao, Y., et al. (2015) Genetic Features of Pulmonary Adenocarcinoma Presenting with Ground-Glass Nodules: The Differences between Nodules with and without Growth. Annals of Oncology, 26, 156-161. https://doi.org/10.1093/annonc/mdu505
Poinen-Rughooputh, S., Rughooputh, M., Guo, Y., et al. (2016) Occupational Exposure to Silica Dust and Risk of Lung Cancer: An Updated Meta-Analysis of Epidemiological Studies. BMC Public Health, 16, 1137. https://doi.org/10.1186/s12889-016-3791-5
Ramanakumar, A., Parent, M. and Siemiatycki, J. (2007) Risk of Lung Cancer from Residential Heating and Cooking Fuels in Montreal, Canada. American Journal of Epidemiology, 165, 634-642. https://doi.org/10.1093/aje/kwk117
Kobayashi, Y., Sakao, Y., Deshpande, G., et al. (2014) The Association between Baseline Clinical-Radiological Characteristics and Growth of Pulmonary Nodules with Ground-Glass Opacity. Lung Cancer (Amsterdam, Netherlands), 83, 61-66. https://doi.org/10.1016/j.lungcan.2013.10.017
Lung Cancer Group of Respiratory Branch of Chinese Medical Association, Expert Group of China Lung Cancer Prevention and Control Alliance (2018) Chinese Expert Consensus on Diagnosis and Treatment of Pulmonary Nodules (2018 Edition). Chinese Journal of Tuberculosis and Respiratory Medicine, 41, 763-771.
Travis, W.D., Brambilla, E., Noguchi, M., et al. (2011) International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. Journal of Thoracic Oncology, 6, 244-285. https://doi.org/10.1097/JTO.0b013e318206a221
Macmahon, H., Naidich, D.P., Goo, J.M., et al. (2017) Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology, 2017, Article ID: 161659. https://doi.org/10.1148/radiol.2017161659
Ludwig, M., Chipon, E., Cohen, J., et al. (2019) Detection of Pulmonary Nodules: A Clinical Study Protocol to Compare Ultra-Low Dose Chest CT and Standard Low-Dose CT Using ASIR-V. BMJ Open, 9, e025661. https://doi.org/10.1136/bmjopen-2018-025661
Wang, X.M., Lv, L., Zheng, Q.Y., et al. (2018) Differential Diagnostic Value of 64-Slice Spiral Computed Tomography in Solitary Pulmonary Nodule. Experimental and Therapeutic Medicine, 15, 4703-4708. https://doi.org/10.3892/etm.2018.6041
Hu, H.Y., Wang, Q.G., Tang, H.M., et al. (2016) Multi-Slice Computed Tomography Characteristics of Solitary Pulmonary Ground-Glass Nodules: Differences between Malignant and Benign. Thoracic Cancer, 7, 80-87. https://doi.org/10.1111/1759-7714.12280
Silvestri, G.A., Tanner, N.T., Kearney, P., et al. (2018) Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign from Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest, 154, 491-500.
Sullivan, F.M., Mair, F.S. anderson, W., et al. (2020) Earlier Diagnosis of Lung Cancer in a Randomised Trial of an Autoantibody Blood Test Followed by Imaging. European Respiratory Journal, 57, Article ID: 2000670. https://doi.org/10.1183/13993003.00670-2020
Detterbeck, F.C., Nicholson, A.G., Franklin, W.A., et al. (2016) The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers With Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification. Journal of Thoracic Oncology, 11, 639-650.
Li, H., Dong, S., Zhang, D., et al. (2021) Targeted Sequencing Facilitated Diagnosis of an Uncommon Patient Harboring both Multiple Primary and Intrapulmonary Metastatic Lung Cancer: A Case Report. OncoTargets and Therapy, 14, 3455-3459. https://doi.org/10.2147/OTT.S309155
Detterbeck, F.C., Boffa, D.J., Kim, A.W. and Tanoue, L.T. (2017) The Eighth Edition Lung Cancer Stage Classification. Chest, 151, 193-203. https://doi.org/10.1016/j.chest.2016.10.010
Nicholson, A., Viola, P., Torkko, K., et al. (2017) Reproducibility of Comprehensive Histologic Assessment and Refining Histologic Criteria in P Staging of Multiple Tumor Nodules. Journal of Thoracic Oncology, 12, S1131-S1132. https://doi.org/10.1016/j.jtho.2016.11.1587
Homer, R.J. (2015) Pathologists’ Staging of Multiple Foci of Lung Cancer: Poor Concordance in Absence of Dramatic Histologic or Molecular Differences. American Journal of Clinical Pathology, 143, 701-706. https://doi.org/10.1309/AJCPNBWF55VGKOIW
Shinozaki-Ushiku, A., Kohsaka, S., Kage, H., et al. (2020) Genomic Profiling of Multiple Primary Cancers Including Synchronous Lung Adenocarcinoma and Bilateral Malignant Mesotheliomas: Identification of a Novel BAP1 Germline Variant. Pathology International, 70, 775-780. https://doi.org/10.1111/pin.12977
Kozower, B.D., Larner, J.M., Detterbeck, F.C. and Jones, D.R. (2013) Special Treatment Issues in Non-Small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 143, e369S-399S. https://doi.org/10.1378/chest.12-2362
Cheng, H., Lei, B.-F., Peng, P.-J., et al. (2017) Histologic Lung Cancer Subtype Differentiates Synchronous Multiple Primary Lung Adenocarcinomas from Intrapulmonary Metastases. Journal of Surgical Research, 211, 215-222. https://doi.org/10.1016/j.jss.2016.11.050
Finley, D.J., Yoshizawa, A., Travis, W., et al. (2010) Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung Cancers. Journal of Thoracic Oncology, 5, 197-205. https://doi.org/10.1097/JTO.0b013e3181c814c5
Chang, J.C., Alex, D., Bott, M., et al. (2019) Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas from Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clinical Cancer Research, 25, 7113-7125. https://doi.org/10.1158/1078-0432.CCR-19-1700
Voltolini, L., Rapicetta, C., Luzzi, L., et al. (2010) Surgical Treatment of Synchronous Multiple Lung Cancer Located in a Different Lobe or Lung: High Survival in Node-Negative Subgroup. European Journal of Cardio-Thoracic Surgery, 37, 1198-204. https://doi.org/10.1016/j.ejcts.2009.11.025
Saab, J., Zia, H., Mathew, S., Kluk, M., Narula, N. and Fernandes, H. (2017) Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis. Translational Oncology, 10, 442-449. https://doi.org/10.1016/j.tranon.2017.02.009
Vignot, S., Frampton, G.M., Soria, J.C., et al. (2013) Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations between Primary Tumor and Metastases from Patients with Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 31, 2167-2172. https://doi.org/10.1200/JCO.2012.47.7737
Tang, X., Shigematsu, H., Bekele, B.N., et al. (2005) EGFR Tyro-Sine Kinase Domain Mutations Are Detected in Histologically Normal Respiratory Epithelium in Lung Cancer Patients. Cancer Research, 65, 7568-7572. https://doi.org/10.1158/0008-5472.CAN-05-1705
Gazdar, A., Robinson, L., Oliver, D., et al. (2014) Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations. Journal of Thoracic Oncology, 9, 456-463. https://doi.org/10.1097/JTO.0000000000000130
Cecilia, B., et al. (2008) Comparison between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-Small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites. Journal of Thoracic Oncology, 3, 18-22. https://doi.org/10.1097/JTO.0b013e31815e8ba2
Schmid, K., Oehl, N., Wrba, F., et al. (2009) EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15, 4554. https://doi.org/10.1158/1078-0432.CCR-09-0089
Nicolas, G., et al. (2009) Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Non-Small Cell Carcinomas from Metastases. The American Journal of Surgical Pathology, 33, 1752-1764. https://doi.org/10.1097/PAS.0b013e3181b8cf03
Nicolas, G., et al. (2009) Genomic and Mutational Profiling to Assess Clonal Relationships between Multiple Non-Small Cell Lung Cancers. Clinical Cancer Research, 15, 5184-5190. https://doi.org/10.1158/1078-0432.CCR-09-0594
Gigliotti, F., Wiley, J.A. and Harmsen, A.G. (1998) Immunization with Pneumocystis carinii gpA Is Immunogenic but Not Protective in a Mouse Model of P. carinii Pneumonia. Infection and Immunity, 66, 3179-3182. https://doi.org/10.1128/IAI.66.7.3179-3182.1998
Sugimoto, H., Mundel, T.M., Kieran, M.W. and Kalluri, R. (2006) Identification of Fibroblast Heterogeneity in the Tumor Microenvironment. Cancer Biology & Therapy, 5, 1640-1646. https://doi.org/10.4161/cbt.5.12.3354
He, Y.Y., Liu, X.G., Wang, H., et al. (2021) Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma. Small Methods, 5, e2100082. https://doi.org/10.1002/smtd.202100082
Kurebayashi, Y., Emoto, K., Hayashi, Y., Kamiyama, I., Ohtsuka, T., Asamura, H., et al. (2016) Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator. Cancer Immunology Research, 4, 234-247. https://doi.org/10.1158/2326-6066.CIR-15-0214
Yonit, L. and Miriam, M. (2013) Macrophages: Gatekeepers of Tissue Integrity. Cancer Immunology Research, 1, 201-209. https://doi.org/10.1158/2326-6066.CIR-13-0117
Ginhoux, F. and Jung, S. (2014) Monocytes and Macrophages: Developmental Pathways and Tissue Homeostasis. Nature Reviews Immunology, 14, 392-404. https://doi.org/10.1038/nri3671
Guilliams, M., Lambrecht, B.N. and Hammad, H. (2013) Division of Labor between Lung Dendritic Cells and Macrophages in the Defense against Pulmonary Infections. Mucosal Immunology, 6, 464-473. https://doi.org/10.1038/mi.2013.14
Goc, J., Germain, C., Vo-Bourgais, T.K., et al. (2014) Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells. Cancer Research, 74, 705-715. https://doi.org/10.1158/0008-5472.CAN-13-1342
Virk, H., Arthur, G. and Bradding, P. (2016) Mast Cells and Their Activation in Lung Disease. Translational Research, 174, 60-76. https://doi.org/10.1016/j.trsl.2016.01.005
Imada, A., Shijubo, N., Kojima, H., et al. (2000) Mast Cells Correlate with Angiogenesis and Poor Outcome in Stage I Lung Adenocarcinoma. European Respiratory Journal, 15, 1087-1093. https://doi.org/10.1034/j.1399-3003.2000.01517.x
Kobayashi, K., Nishioka, M., Kohno, T., et al. (2004) Identification of Genes Whose Expression Is Upregulated in Lung Adenocarcinoma Cells in Comparison with Type II Alveolar Cells and Bronchiolar Epithelial Cells in Vivo. Oncogene, 23, 3089-3096. https://doi.org/10.1038/sj.onc.1207433